ABSTRACT
PURPOSE: This study aimed to evaluate the effect and individual responsiveness after 12 (12wk) and 24 weeks (24wk) of physical exercise (PE) and nutritional guidance (NG) on metabolic syndrome (MetS) criteria and hepatic parameters in overweight adolescents. METHODS: The study comprised 94 overweight adolescents, aged between 10 and 16 years old, from both sexes, allocated into groups: PE and NG (PENGG, n = 64) and control with NG (NGCG, n = 30). Variables were collected at baseline, 12wk, and 24wk. Weight, height, abdominal circumference (AC), blood pressure, and peak oxygen consumption (VO2peak), as well as insulin, triglycerides (TAG), high-density lipoprotein (HDL-c), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were evaluated. HOMA-IR and QUICKI were calculated. PE session consisted of 45 min of indoor cycling, 45 min of walking, and 20 min of stretching, three times a week. The NG consisted of three collective sessions in the first 12wk. Anova, effect size, and prevalence of responders were used for statistical analysis. RESULTS: The PENGG12wk reduced anthropometric and metabolic measurements, while increased VO2peak and HDL-c. The PEG24wk promoted anthropometric, blood pressure, metabolic, and VO2peak improvements, but participants without PE returned to pre-exercise status and presented worsening AST and ALT concentrations. Frequencies of respondents in PENGG12wk versus (vs) NGCG12wk were, respectively, AC (69.1% vs 17.6%, p < 0.01), HDL-c (87.2% vs 23.5%, p < 0.01), TAG (67.3% vs 41.7%, p = 0.05) and ALT (45.5% vs 5,9%; p = 0.003). CONCLUSION: Interventions with PE were effective to reduce MetS components in 12wk and maintenance in 24wk, showing anthropometric, metabolic, and VO2peak improvements. Higher individual responses were observed in 12wk and in 24wk, important changes in overweight adolescent's therapy. LEVEL OF EVIDENCE: Level I, evidence obtained from well-designed controlled trials randomization. TRIAL REGISTRATION NUMBER AND DATE OF REGISTRATION: Brazilian Registry of Clinical Trials (RBR-4v6h7b) and date of registration April 4th, 2020.
Subject(s)
Metabolic Syndrome/classification , Pediatric Obesity/complications , Adolescent , Analysis of Variance , Body Mass Index , Brazil/epidemiology , Child , Female , Humans , Liver/abnormalities , Liver/metabolism , Liver/physiopathology , Liver Function Tests/methods , Liver Function Tests/statistics & numerical data , Male , Metabolic Syndrome/diagnosis , Metabolic Syndrome/epidemiology , Pediatric Obesity/blood , Pediatric Obesity/epidemiology , Risk Factors , Statistics, NonparametricABSTRACT
BACKGROUND: Array-comparative genomic hybridization (array-CGH) is a widely used technique to detect copy number variants (CNVs) associated with developmental delay/intellectual disability (DD/ID). AIMS: Identification of genomic disorders in DD/ID. MATERIALS AND METHODS: We performed a comprehensive array-CGH investigation of 1,015 consecutive cases with DD/ID and combined literature mining, genetic evidence, evolutionary constraint scores, and functional information in order to assess the pathogenicity of the CNVs. RESULTS: We identified non-benign CNVs in 29% of patients. Amongst the pathogenic variants (11%), detected with a yield consistent with the literature, we found rare genomic disorders and CNVs spanning known disease genes. We further identified and discussed 51 cases with likely pathogenic CNVs spanning novel candidate genes, including genes encoding synaptic components and/or proteins involved in corticogenesis. Additionally, we identified two deletions spanning potential Topological Associated Domain (TAD) boundaries probably affecting the regulatory landscape. DISCUSSION AND CONCLUSION: We show how phenotypic and genetic analyses of array-CGH data allow unraveling complex cases, identifying rare disease genes, and revealing unexpected position effects.
Subject(s)
DNA Copy Number Variations/genetics , DNA-Binding Proteins/genetics , Developmental Disabilities/genetics , Intellectual Disability/genetics , Adolescent , Adult , Child , Child, Preschool , Chromosomal Position Effects/genetics , Chromosome Aberrations , Comparative Genomic Hybridization , Developmental Disabilities/pathology , Female , Genetic Association Studies , Genomics , Humans , Infant , Intellectual Disability/pathology , Male , Pedigree , Phenotype , Sequence Deletion/genetics , Young AdultABSTRACT
The mode of inheritance of Alport syndrome (ATS) has long been controversial. In 1927, the disease was hypothesized as a dominant condition in which males were more severely affected than females. In 1990, it was considered an X-linked (XL) semidominant condition, due to COL4A5 mutations. Later on, a rare autosomal recessive (AR) form due to COL4A3/COL4A4 mutations was identified. An autosomal dominant (AD) form was testified more recently by the description of some large pedigrees but the real existence of this form is still questioned by many and its exact prevalence is unknown. The introduction of next generation sequencing (NGS) allowed us to perform an unbiased simultaneous COL4A3-COL4A4-COL4A5 analysis in 87 Italian families (273 individuals) with clinical suspicion of ATS. In 48 of them (55%), a mutation in one of the three genes was identified: the inheritance was XL semidominant in 65%, recessive in 4% and most interestingly AD in 31% (15 families). The AD form must therefore be seriously taken into account in all pedigrees with affected individuals in each generation. Furthermore, a high frequency of mutations (>50%) was shown in patients with only 1 or 2 clinical criteria, suggesting NGS as first-level analysis in cases with a clinical suspicion of ATS.
Subject(s)
Autoantigens/genetics , Collagen Type IV/genetics , Inheritance Patterns/genetics , Nephritis, Hereditary/genetics , Base Sequence , Female , High-Throughput Nucleotide Sequencing , Humans , Italy , Male , Molecular Sequence Data , Mutation/genetics , PedigreeABSTRACT
A study using 144 one-day-old Arbor Acres broilers was conducted to assess the effects of dried ginger root (Zingiber officinale) that was processed to particle sizes of 300, 149, 74, 37, and 8.4 microm on growth performance, antioxidant status, and serum metabolites of broiler chickens. The birds were housed in 24 wire cages in an environmentally controlled room. Dietary treatments were no supplementation (control) and supplementation with ginger root processed to 5 particle sizes at the level of 5 g/kg of diet. Average daily gain, ADFI, and feed conversion rate of chicks of each cage were measured weekly. Blood samples from 8 broilers per treatment were obtained at d 21 and 42 of the experiment to determine antioxidant enzymatic activities and metabolites in the serum, and the birds were subsequently killed to determine carcass yield and abdominal fat content. All broilers had similar ADFI or feed conversion rate over the entire experimental period. However, broilers supplemented with ginger powder tended to have higher ADG and had greater (P=0.014) carcass yield compared with that of the control. Supplementation of ginger increased (P<0.001) activities of total superoxide dismutase and glutathione peroxidase but reduced (P<0.01) concentrations of malondialdehyde and cholesterol in serum of broilers at 21 and 42 d of age. Concentration of total protein in serum of ginger-supplemented broilers tended (P=0.092) to be higher at 21 d and was higher (P=0.002) at 42 d of age compared with that of control broilers. Reducing particle size of ginger powder linearly reduced (P<0.05) cholesterol (d 21) and linearly increased (P<0.05) glutathione peroxidase (d 21), total superoxide dismutase (d 42), and total protein (d 21 and 42). Supplementation of ginger at the level of 5 g/kg improved antioxidant status of broilers and the efficacy was enhanced as the particle size was reduced from 300 to 37 microm.